LAS VEGAS, NV–(Marketwired – August 05, 2016) – CV Sciences, Inc. (OTCBB: CVSI), is pleased to announce the latest addition to its consumer products division, Purified Liquids™, which offers the highest quality, premium CBD vape e-liquids available on the market today. The launch of this brand targets the booming vape industry, which is expected to reach US$32.11 billion worldwide by 2021, according to Research and Markets Assessment of the World Vape Market.
“Over the last 2 years, we observed the vape industry blossom into the powerhouse that it is today,” stated Michael J. Mona, III, co-founder and chief operating officer at CV Sciences. “As the leader in hemp-derived CBD oil, our unwavering commitment to excellence resulted in over a year of research and development by our in-house laboratory team. In the end, we created a product line of consistently pure, safe, and solvent-free CBD vape e-liquids of which we are very proud.”
Made from 99.9% CBD from hemp-derived crystals and containing 0% THC, each Purified Liquids™ product provides at least 360mg of hemp-derived CBD per 30mL bottle, offering 12mg of CBD per mL.
Purified Liquids™ is proud to introduce the first two delicious CBD vape flavors:
  • Inertia: Guava Honeydew with tangy, fruit-forward, and tropical notes
  • Isotope: Watermelon Chill with a refreshing, sweet, clean taste and hints of spearmint

The bottles containing Purified Liquids™ were specially designed to block UV light. By blocking UV light, the CBD vape liquids are protected against oxidation and separation, leaving a great tasting product every time.
Using a proprietary process in CV Sciences’ state-of-the-art GMP laboratory, Purified Liquids’™ solvent-free solutions are unique from other CBD vape products. CBD crystals are derived from 100% agricultural hemp as opposed to synthetic chemicals or compounds. Each product is thoroughly lab tested to ensure the absence of harmful chemicals, heavy metals, solvents, or pesticides. Third party certificates of analysis are available upon request.
Purified Liquids™ are available for sale online and for wholesale distribution.
ABOUT CV SCIENCES: CV Sciences, Inc. (OTCBB: CVSI), formerly CannaVest Corp., located in Las Vegas, Nevada, focuses on drug development activities on products containing cannabidiol (CBD) as the active pharmaceutical ingredient, and is engaged in the development, marketing and sale of end consumer products containing CBD, which is refined into its PlusCBD Oil™ and Purified Liquids™ brands. Learn more about Purified Liquids™ at PurifiedLiquids.com.

For more information about CV Sciences, Inc. or Purified Liquids™, please contact:
Alex Huber
alex.huber@cvsciences.com
  • Company has received UK Continuing Professional Development (“CPD”) accreditation for its global education platform, Khiron Academy
  • UK medical professionals may now earn CPD credits through Khiron’s medical cannabis education program
  • The Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK, to increase patient access via medical cannabis education
  • As a leading international medical cannabis educator, nearly 1,000 medical professionals in Latin America and the United Kingdom have registered for, or completed, Khiron Academy training

 Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe is pleased to announce it has received UK Continuing Professional Development (“CPD”) accreditation for Khiron Academy, the Company’s global medical cannabis education platform.

Additionally, following its accreditation, the Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK and fellow founding member of Project Twenty21, to increase patient access through medical cannabis education initially. Khiron Academy will be made available to prescribers in the UK that have registered with Cellen’s MedCanHub, an emerging education portal. Cellen is market leader, widely recognized for also launching the UK’s first digital pain clinic, Leva.

Keep reading... Show less

TRACE’s plant-based and alkaline wellness products to expand into key markets of Japan, China and the Philippines

Emerging leader in innovative health and wellness beverages and consumer products, BevCanna Enterprises Inc . ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today its anticipated expansion into the Asia Pacific region, through its wholly-owned subsidiary Naturo Group. After completing a comprehensive market, distribution and partner assessment, the Company intends to initially launch its portfolio of TRACE health and wellness products in the key markets of Japan, China, and the Philippines, through multi-channel distribution outlets including e-commerce, retail, and wholesale.

Keep reading... Show less

Trulieve acquires dispensary permits from Solevo Wellness West Virginia LLC for $650,000

Trulieve Cannabis Corp . (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States and the largest cannabis company in Florida announced today that it acquired Solevo Wellness West Virginia LLC (“Solevo”) and its three West Virginia dispensary permits for $650,000 . Solevo was awarded two permits in Morgantown and one in Parkersburg in January 2021 as part of the West Virginia application process.

Keep reading... Show less

Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) a wellness company that develops and sells sustainable, plant-based products, is pleased to announce that it’s Jusu Home and Body line is now available for purchase on Faire Wholesale Marketplace (“Faire” or “www.faire.com”), an online wholesale marketplace valued at US $2.5 billion. Jusu Home and Body products are currently featured in their “New Arrivals” section.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/80230_8c77c54544bf884c_001.jpg

Keep reading... Show less

 Aion Therapeutic Inc. (CSE: AION) (” Aion Therapeutic ” or the ” Company “) today announced that it has retained KCSA Strategic Communications (” KCSA “), a leading New York City -based communications firm.

Keep reading... Show less